Scale for the Assessment of Chemotherpy-Induced Nausea and Vomits: Translation and Transcultural Adaptation
DOI:
https://doi.org/10.32635/2176-9745.RBC.2022v68n1.1423Keywords:
validation study, nausea, vomiting, drug therapy, medical oncologyAbstract
Introduction: Chemotherapy-induced nausea and vomiting affects nearly 70-80% of patients with cancer. To achieve a better treatment it is important to utilize an adequate instrument to assess these symptoms. Objective: To translate and culturally adapt the Morrow Assessment of Nausea and Emesis Scale to the Brazilian context. Method: Survey and correlational study, with the translation and cultural adaptation of the scale according to the protocol of the European Organization for Research and Treatment of Cancer – Quality of Life Group (EORTC-QLG). The sample consisted of 160 patients undergoing chemotherapy treatment in an oncology clinic. In the validation process, multimethod correlation analyses were carried out among the items of the Morrow Assessment of Nausea and Emesis Scale items and the scores of the numerical visual scales of nausea and vomits at the level of p<0.05. Results: The author of the scale approved the translation process. The Morrow Assessment of Nausea and Emesis scale and the numerical scales presented significant correlations (p<0.01; p<0.05), considering that the items presenting stronger correlation with the numerical scales were those addressing post-chemotherapy assessment of nausea and vomit. On the other hand, the items for pre-chemotherapy assessment of these symptoms and use of the antiemetic drugs and their efficacy presented weak associations with the numerical scales. Conclusion: The Morrow Assessment of Nausea and Emesis scale was adequate for the assessment of chemotherapy-induced nausea and vomiting in the Brazilian context.
Downloads
References
World Health Organization. WHO report on cancer: setting priorities, investing wisely and providing care for all. Geneva: WHO; 2020.
Instituto Nacional de Câncer José Alencar Gomes da Silva. Estimativa 2020: incidência de câncer no Brasil [Internet]. Rio de Janeiro: INCA; 2019 [acesso 2020 nov 23]. Disponível em: https://www.inca.gov.br/sites/ufu.sti.inca.local/files/media/document/estimativa-2020-incidencia-de-cancer-no-brasil.pdf
Reis M. Farmacogenética aplicada ao câncer. Quimioterapia individualizada e especificidade molecular. Medicina (Ribeirão Preto). 2006;39(4):577-86. doi: https://doi.org/10.11606/issn.2176-7262.v39i4p577-586 DOI: https://doi.org/10.11606/issn.2176-7262.v39i4p577-586
Wang W, Lou G, Zhang Y. Olanzapine with ondansetron and dexamethasone for the prevention of cisplatin-based chemotherapy-induced nausea and vomiting in lung câncer. Medicine (Baltimore). 2018;97(37):e12331. doi: https://doi.org/10.1097/MD.0000000000012331 DOI: https://doi.org/10.1097/MD.0000000000012331
Karimi S, Makhsosi BR, Seyedi-Andi SJ, et al. Surveying the effect of a self-care education program on severity of nausea and emesis in colorectal cancer patients under chemotherapy. J Multidiscip Healthc. 2017;10:301-7. doi: https://doi.org/10.2147/JMDH.S131111 DOI: https://doi.org/10.2147/JMDH.S131111
Gardona RGB, Barbosa DA. The importance of clinical practice supported by health assessment tools. Rev Bras Enferm. 2018;71(4):1815-6. doi: https://doi.org/10.1590/0034-7167-2018710401 DOI: https://doi.org/10.1590/0034-7167-2018710401
Epstein J, Osborne RH, Elsworth GR, et al. Crosscultural adaptation of the Health Education Impact Questionnaire: experimental study showed expert committee, not back-translation, added value. J Clin Epidemiol. 2015;68(4):360-9. doi: https://doi.org/10.1016/j.jclinepi.2013.07.013 DOI: https://doi.org/10.1016/j.jclinepi.2013.07.013
Morrow GR. A patient report measure for the quantification of chemotherapy induced nausea and emesis: psychometric properties of the Morrow assessment of nausea and emesis (MANE). Br J Cancer Suppl. 1992;19:S72-4.
Morrow GR. Methodology in behavioral and psychosocial cancer research. The assessment of nausea and vomiting. Past problems, current issues and suggestions for future research. Cancer. 1984;53(10 Suppl):2267-80. DOI: https://doi.org/10.1002/cncr.1984.53.s10.2267
Kulis D, Bottomley A, Velikova G, et al. EORTC Quality of life group translation procedure. 4th ed. Brussels: EORTC; 2017.
Instituto Nacional de Câncer José Alencar Gomes da Silva. Integrador RHC: registro hospitalar de câncer [Internet]. Versão 3.2. Rio de Janeiro: INCA. 2012 dez 14 – [acesso 2020 abr 3]. Disponível em: https://bit.ly/38MyrBF
ECOG-ACRIN Cancer Research Group [Internet]. Philadelphia, PA: ECOG_AGRIN; c2012-2020. ECOG performance status; [cited 2020 Aug 17]. Available from: https://ecog-acrin.org/resources/ecog-performance-status
Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649-55. DOI: https://doi.org/10.1097/00000421-198212000-00014
Wood JM, Chapman K, Eilers J. Tools for assessing nausea, vomiting, and retching: a literature review. Cancer Nurs. 2011;34(1):E14-24. Review. doi: https://doi.org/10.1097/ncc.0b013e3181e2cd79 DOI: https://doi.org/10.1097/NCC.0b013e3181e2cd79
Jaeschke R, Singer J, Guyatt GH. A comparison of sevenpoint and visual analogue scales. Data from a randomized trial. Control Clin Trials. 1990;11(1):43-51. doi: https://doi.org/10.1016/0197-2456(90)90031-v DOI: https://doi.org/10.1016/0197-2456(90)90031-V
Meek R, Egerton-Warburton D, Mee MJ, et al. Measurement and monitoring of nausea severity in emergency department patients: a comparison of scales and exploration of treatment efficacy outcome measures. Acad Emerg Med. 2015;22(6):685-93. doi: https://doi.org/10.1111/acem.12685 DOI: https://doi.org/10.1111/acem.12685
Nunnally JC, Bernstein IH. Psychometric theory. 3rd ed. New York: McGraw Hill; 1994. (McGraw Hill series in psychology).
Hair JF, Black WC, Babin BJ, et al. Análise multivariada de dados. 6. ed. Porto Alegre, SC: Bookman; 2009.
Dancey CP, Reidy J. Estatística sem matemática: para psicologia usando SPSS para Windows. 3. ed. Porto Alegre, SC: Artmed; 2006.
Pereira TJ, Puggina AC. Validation of the self-assessment of communication skills and professionalism for nurses. Rev Bras Enferm. 2017;70(3):588-94. doi: https://doi.org/10.1590/0034-7167-2016-0133 DOI: https://doi.org/10.1590/0034-7167-2016-0133
Escobar Y, Cajaraville G, Virizuela JA, et al. Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study. Support Care Cancer. 2015;23(9):2833-40. doi: https://doi.org/10.1007/s00520-015-2809-3. Erratum in: Support Care Cancer. 2015;23(9):2841. doi: https://doi.org/10.1007/s00520-015-2842-2 DOI: https://doi.org/10.1007/s00520-015-2842-2
Pearce A, Hass M, Viney R, et al. Incidence and severity of self-reported chemotherapy side effects in routine care: a prospective cohort study. PLoS One. 2017;12(10):e0184360. doi: https://doi.org/10.1371/journal.pone.0184360 DOI: https://doi.org/10.1371/journal.pone.0184360
Puri S, Hyland KA, Weiss KC, et al. Prediction of chemotherapy-induced nausea and vomiting from patient-reported and genetic risk factors. Support Care Cancer. 2018;26(8):2911-8. doi: https://doi.org/10.1007/s00520-018-4120-6 DOI: https://doi.org/10.1007/s00520-018-4120-6
Razvi Y, Chan S, McFarlane E, et al. ASCO, NCCN, MASCC/ESMO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in adult patients. Support Care Cancer. 2019;27(1):87-95. doi: https://doi.org/10.1007/s00520-018-4464-y DOI: https://doi.org/10.1007/s00520-018-4464-y
Adel N. Overview of chemotherapy-induced nausea and vomiting and evidence-based therapies. Am J Manag Care. 2017;23(14 Suppl):S259-S65.
Bošnjak SM, Gralla RJ, Schwartzberg L. Prevention of chemotherapy-induced nausea: the role of neurokinin-1 (NK1) receptor antagonists. Support Care Cancer. 2017;25(5):1661-71. doi: https://doi.org/10.1007/s00520-017-3585-z DOI: https://doi.org/10.1007/s00520-017-3585-z
Morrow GR. Methodology and assessment in clinical anti-emetic research: a meta-analysis of outcome parameters. Br J Cancer Suppl. 1992;19:S38-S41.
Maia AES, Grello FAC, Cunha KC. Perfil sociodemográfico e clínico de pacientes com câncer cadastrados no programa de visita domiciliar de um hospital da rede pública. Rev Bras Cancerol. 2021;67(2):e-05864. doi: https://doi.org/10.32635/2176-9745.RBC.2021v67n2.864 DOI: https://doi.org/10.32635/2176-9745.RBC.2021v67n2.864
Roscoe JA, Morrow GR, Aapro MS, et al. Anticipatory Nausea and Vomiting. Support Care Cancer. 2011;19(10):1533-8. doi: https://doi.org/10.1007/s00520-010-0980-0 DOI: https://doi.org/10.1007/s00520-010-0980-0
Castro MC, Araújo SA, Mendes TR, et al. Effectiveness of antiemetics in control of antineoplastic chemotherapyinduced emesis at home. Acta Paul Enferm. 2014;27(5):412-18. doi: https://doi.org/10.1590/1982-0194201400069 DOI: https://doi.org/10.1590/1982-0194201400069
Published
How to Cite
Issue
Section
License
Os direitos morais e intelectuais dos artigos pertencem aos respectivos autores, que concedem à RBC o direito de publicação.
This work is licensed under a Creative Commons Attribution 4.0 International License.
